Real-Time Monitoring of Bacterial Infection In Vivo: Development of Bioluminescent Staphylococcal Foreign-Body and Deep-Thigh-Wound Mouse Infection Models

ABSTRACT Staphylococcal infections associated with catheter and prosthetic implants are difficult to eradicate and often lead to chronic infections. Development of novel antibacterial therapies requires simple, reliable, and relevant models for infection. Using bioluminescent Staphylococcus aureus, we have adapted the existing foreign-body and deep-wound mouse models of staphylococcal infection to allow real-time monitoring of the bacterial colonization of catheters or tissues. This approach also enables kinetic measurements of bacterial growth and clearance in each infected animal. Persistence of infection was observed throughout the course of the study until termination of the experiment at day 16 in a deep-wound model and day 21 in the foreign-body model, providing sufficient time to test the effects of antibacterial compounds. The usefulness of both animal models was assessed by using linezolid as a test compound and comparing bioluminescent measurements to bacterial counts. In the foreign-body model, a three-dose antibiotic regimen (2, 5, and 24 h after infection) resulted in a decrease in both luminescence and bacterial counts recovered from the implant compared to those of the mock-treated infected mice. In addition, linezolid treatment prevented the formation of subcutaneous abscesses, although it did not completely resolve the infection. In the thigh model, the same treatment regimen resulted in complete resolution of the luminescent signal, which correlated with clearance of the bacteria from the thighs.

[1]  D. Goldmann,et al.  Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. , 2000, Journal of biotechnology.

[2]  J. Musser,et al.  Murine model of cutaneous infection with gram-positive cocci , 1992, Infection and immunity.

[3]  P. Iversen,et al.  Validation of a Noninvasive, Real-Time Imaging Technology Using Bioluminescent Escherichia coli in the Neutropenic Mouse Thigh Model of Infection , 2001, Antimicrobial Agents and Chemotherapy.

[4]  Ronald N. Jones,et al.  In Vitro Evaluation of AZD2563, a Novel Oxazolidinone, against 603 Recent Staphylococcal Isolates , 2002, Antimicrobial Agents and Chemotherapy.

[5]  J. Abb In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method. , 2002, Diagnostic microbiology and infectious disease.

[6]  P. Lipsett,et al.  Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit , 2002, Postgraduate medical journal.

[7]  P. Fey,et al.  Characterization of the Importance of Polysaccharide Intercellular Adhesin/Hemagglutinin of Staphylococcus epidermidis in the Pathogenesis of Biomaterial-Based Infection in a Mouse Foreign Body Infection Model , 1999, Infection and Immunity.

[8]  H. Chambers,et al.  The changing epidemiology of Staphylococcus aureus? , 2001, Emerging infectious diseases.

[9]  Marc Lipsitch,et al.  Visualizing Pneumococcal Infections in the Lungs of Live Mice Using Bioluminescent Streptococcus pneumoniaeTransformed with a Novel Gram-Positive luxTransposon , 2001, Infection and Immunity.

[10]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[11]  C. Easmon,et al.  Effect of cyclophosphamide on delayed hypersensitivity to Staphylococcus aureus in mice. , 1977, Immunology.

[12]  Kevin P. Francis,et al.  Monitoring Bioluminescent Staphylococcus aureusInfections in Living Mice Using a Novel luxABCDEConstruct , 2000, Infection and Immunity.

[13]  W. Craig,et al.  Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections. , 1991, The Journal of antimicrobial chemotherapy.

[14]  J. Costerton,et al.  A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. , 1982, Circulation.

[15]  C. Contag,et al.  Revealing the spatiotemporal patterns of bacterial infectious diseases using bioluminescent pathogens and whole body imaging. , 2001, Contributions to microbiology.

[16]  J. Peyton,et al.  Immunosuppression augments growth of graft-adherent Staphylococcus epidermidis. , 1995, Archives of surgery.

[17]  R. Jordan,et al.  Effects of 2 different anti-tumor necrosis factor-alpha agents in a primate model of subcutaneous abscess formation. , 2002, Journal of Infectious Diseases.

[18]  M. Rybak,et al.  In Vitro Activities of Quinupristin-Dalfopristin and Cefepime, Alone and in Combination with Various Antimicrobials, against Multidrug-Resistant Staphylococci and Enterococci in an In Vitro Pharmacodynamic Model , 2002, Antimicrobial Agents and Chemotherapy.

[19]  N. Melchior,et al.  In-vitro evaluation of ampicillin/brobactam and comparison with other beta-lactam antibiotics. , 1991, The Journal of antimicrobial chemotherapy.

[20]  A. Conde Staphylococcus aureus infections. , 1998, The New England journal of medicine.

[21]  P. Fey,et al.  Characterization of Staphylococcus epidermidisPolysaccharide Intercellular Adhesin/Hemagglutinin in the Pathogenesis of Intravascular Catheter-Associated Infection in a Rat Model , 1999, Infection and Immunity.

[22]  R. Wenzel,et al.  The impact of hospital-acquired bloodstream infections. , 2001, Emerging infectious diseases.

[23]  G. W. Snedecor STATISTICAL METHODS , 1967 .

[24]  T. Foster,et al.  Surface protein adhesins of Staphylococcus aureus. , 1998, Trends in microbiology.

[25]  J. Mullins,et al.  Photonic detection of bacterial pathogens in living hosts , 1995, Molecular microbiology.

[26]  J. L. Muñoz Bellido,et al.  In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus. , 2002, International journal of antimicrobial agents.

[27]  A. Widmer,et al.  Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. , 1990, The Journal of infectious diseases.